SMTL ID : 3ozl.1

Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

2 x FLF: 2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID(Non-covalent)

FLF.1: 7 residues within 4Å: Chain A: K.15, L.17, T.106, A.108, L.110, T.119, V.121 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:K.15, A:T.106, A:A.108, A:L.110, A:V.121 Salt bridges: A:K.15 FLF.2: 6 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117, V.121 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:A.108, B:L.110, B:V.121 Salt bridges: B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lima, L.M.T.R. et al., Crystal structure of human transthyretin variant A25T in complex with flufenamic acid. To be Published

Release Date

2011-09-28

Peptides

Transthyretin: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Transthyretin

Related Entries With Identical Sequence